Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial
Maria Domenica Cappellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alì Taher(American University of Beirut Medical Center), Luciana Moro Bueno(Bristol-Myers Squibb (Switzerland)), Abderrahim Khélif(Ente Ospedaliero Ospedali Galliera), Pencho Georgiev(University Multipurpose Hospital for Active Treatment "Sveti Georgi"), Antonis Kattamis, Natalia Holot(Bristol-Myers Squibb (United States)), Kevin H.M. Kuo(University Health Network), Hong-Keng Liew(Ente Ospedaliero Ospedali Galliera), Yinzhi Lai(Bristol-Myers Squibb (United States)), Abdalla Khalil(Rambam Health Care Campus), Thomas D. Coates(Children's Hospital of Los Angeles), Wen‐Ling Kuo(Chang Gung University), Vip Viprakasit(Siriraj Hospital), Lee-Ping Chew(Sarawak General Hospital), Adisak Tantiworawit(Ente Ospedaliero Ospedali Galliera), Loyse Felber Medlin(Bristol-Myers Squibb (Switzerland)), Martina Perin(Bristol-Myers Squibb (Switzerland)), Raffaella Origa(Ospedale Microcitemico), Ana Carolina Giuseppi(Bristol-Myers Squibb (United States)), P. Joy Ho(The University of Sydney)
Cited by 17
Related Papers
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Thalassaemia
|The Lancet|2017|763
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523